Aspalathus linearis (Rooibos)-a functional food targeting cardiovascular disease

Food and Function

Volumn 9, Issue 10, 2018, Pages 5041-5058

  Smith, Carine ^a   Swart, Amanda ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; DRUG INTERACTIONS; FUNCTIONAL FOOD; MEDICAL APPLICATIONS; PLANT EXTRACTS;

CARDIOVASCULAR DISEASE; CLINICAL MANIFESTATION; DISEASE DEVELOPMENT; GENETIC PREDISPOSITION; INDIGENOUS KNOWLEDGE; ISCHEMIC HEART DISEASE; NON-COMMUNICABLE DISEASE; THERAPEUTIC POTENTIALS;

DISEASES;

PLANT EXTRACT;

ANALYSIS; ANIMAL; ASPALATHUS; CARDIOVASCULAR DISEASE; CHEMISTRY; FUNCTIONAL FOOD; GENETICS; HUMAN; MEDICINAL PLANT; METABOLISM;

ANIMALS; ASPALATHUS; CARDIOVASCULAR DISEASES; FUNCTIONAL FOOD; HUMANS; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 85055073624     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c8fo01010b     Document Type: Review

References (148)

1. WHO Traditional medicine strategy: 2014-2023, http://www.who.int/medicines/publications/traditional/trm
2. strategy14 23/en/, (accessed 1 March 2018)
3. WHO fact sheet on global causes of mortality, http://www.who.int/mediacentre/factsheets/fs310/en/
4. B. E. Van Wyk and M.Wink, Medicinal plants of the world, Briza, 2004
5. N. A. Walters A. de Villiers E. Joubert D. de Beer Phenolic profiling of rooibos using off-line comprehensive normal phase countercurrent chromatographyxreversed phase liquid chromatography J. Chromatogr. A 2017 1490 102-114
6. M. A. Stander B. E. Van Wyk M. J. C. Taylor H. S. Long Analysis of Phenolic Compounds in Rooibos Tea (Aspalathus linearis) with a Comparison of Flavonoid-Based Compounds in Natural Populations of Plants from Different Regions J. Agric. Food Chem. 2017 65 10270-10281
7. N. A. Walters A. De Villiers E. Joubert D. De Beer Improved HPLC method for rooibos phenolics targeting changes due to fermentation J. Food Compos. Anal. 2017 55 20-29
8. E. Joubert M. Manley M. Botha Evaluation of spectrophotometric methods for screening of green rooibos (Aspalathus linearis) and green honeybush (Cyclopia genistoides) extracts for high levels of Bio-active compounds Phytochem. Anal. 2008 19 169-178
9. J. L. Marnewick E. Joubert P. Swart F. Van Der Westhuizen W. C. Gelderblom Modulation of hepatic drug metabolizing enzymes and oxidative status by rooibos (Aspalathus linearis) and Honeybush (Cyclopia intermedia), green and black (Camellia sinensis) teas in rats J. Agric. Food Chem. 2003 51 8113-8119
10. E. Joubert T. Beelders D. de Beer C. J. Malherbe A. J. de Villiers G. O. Sigge Variation in phenolic content and antioxidant activity of fermented rooibos herbal tea infusions: role of production season and quality grade J. Agric. Food Chem. 2012 60 9171-9179
11. I. A. Persson M. Josefsson K. Persson R. G. Andersson Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells J. Pharm. Pharmacol. 2006 58 1139-1144
12. V. Y. Waisundara L. Y. Hoon Free radical scavenging ability of Aspalathus linearis in two in vitro models of diabetes and cancer J. Tradit. Complementary Med. 2015 5 174-178
13. R. Kamakura M. J. Son D. de Beer E. Joubert Y. Miura K. Yagasaki Antidiabetic effect of green rooibos (Aspalathus linearis) extract in cultured cells and type 2 diabetic model KK-A(y) mice Cytotechnology 2015 67 699-710
14. O. Ulicna O. Vancova P. Bozek J. Carsky K. Sebekova P. Boor M. Nakano M. Greksak Rooibos tea (Aspalathus linearis) partially prevents oxidative stress in streptozotocin-induced diabetic rats Phys. Res. 2006 55 157-164
15. H. Baba Y. Ohtsuka H. Haruna T. Lee S. Nagata M. Maeda Y. Yamashiro T. Shimizu Studies of anti-inflammatory effects of Rooibos tea in rats Pediatr. Int. 2009 51 700-704
16. W. G. Pantsi J. L. Marnewick A. J. Esterhuyse F. Rautenbach J. van Rooyen Rooibos (Aspalathus linearis) offers cardiac protection against ischaemia/reperfusion in the isolated perfused rat heart Phytomedicine 2011 18 1220-1228
17. O. R. Ajuwon O. O. Oguntibeju J. L. Marnewick Amelioration of lipopolysaccharide-induced liver injury by aqueous rooibos (Aspalathus linearis) extract via inhibition of pro-inflammatory cytokines and oxidative stress BMC Complementary Altern. Med. 2014 14 392
18. I. S. Hong H. Y. Lee H. P. Kim Anti-oxidative effects of Rooibos tea (Aspalathus linearis) on immobilization-induced oxidative stress in rat brain PLoS One 2014 9 e87061
19. P. V. Dludla C. J. Muller E. Joubert J. Louw M. F. Essop K. B. Gabuza S. Ghoor B. Huisamen R. Johnson Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression Molecules 2017 22 1 pii: E129
20. J. L. Marnewick F. Rautenbach I. Venter H. Neethling D. M. Blackhurst P. Wolmarans M. Macharia Effects of rooibos (Aspalathus linearis) on oxidative stress and biochemical parameters in adults at risk for cardiovascular disease J. Ethnopharmacol. 2011 133 46-52
21. P. Ghezzi Role of glutathione in immunity and inflammation in the lung Int. J. Gen. Med. 2011 4 105-113
22. G. Verdile K. N. Keane V. F. Cruzat S. Medic M. Sabale J. Rowles N. Wijesekara R. N. Martins P. E. Fraser P. Newsholme Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease Mediators Inflammation 2015 2015 105828
23. J. F. Ndisang A. Vannacci S. Rastogi Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications Oxid. Med. Cell. Longevity 2014 2014 506948
24. M. Krause J. Rodrigues-Krause C. O'Hagan P. Medlow G. Davison D. Susta C. Boreham P. Newsholme M. O'Donnell C. Murphy G. De Vito The effects of aerobic exercise training at two different intensities in obesity and type 2 diabetes: implications for oxidative stress, low-grade inflammation and nitric oxide production Eur. J. Appl. Physiol. 2014 114 251-260
25. K. S. Petersen C. Smith Ageing-Associated Oxidative Stress and Inflammation Are Alleviated by Products from Grapes Oxid. Med. Cell. Longevity 2016 2016 6236309
26. C. Smith Natural antioxidants in prevention of accelerated ageing: a departure from conventional paradigms required J. Physiol. Biochem. 2018 10.1007/s13105-018-0621-5
27. K. N. Keane V. F. Cruzat R. Carlessi P. I. de Bittencourt Jr. P. Newsholme Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and beta-Cell Dysfunction Oxid. Med. Cell. Longevity 2015 2015 181643
28. C. Smith A. C. Swart Rooibos (Aspalathus linearis) facilitates an anti-inflammatory state, modulating IL-6 and IL-10 while not inhibiting the acute glucorticoid response to a mild novel stressor in vivo J. Funct. Foods 2016 27 42-54
29. E. Katengua-Thamahane J. L. Marnewick O. R. Ajuwon N. N. Chegou G. Szucs P. Ferdinandy T. Csont C. Csonka J. Van Rooyen The combination of red palm oil and rooibos show anti-inflammatory effects in rats J. Inflammation 2014 11 41
30. W. Lee J. S. Bae Anti-inflammatory Effects of Aspalathin and Nothofagin from Rooibos (Aspalathus linearis) In Vitro and In Vivo Inflammation 2015 38 1502-1516
31. K. Thangaraj M. Vaiyapuri Orientin, a C-glycosyl dietary flavone, suppresses colonic cell proliferation and mitigates NF-kappaB mediated inflammatory response in 1,2-dimethylhydrazine induced colorectal carcinogenesis Biomed. Pharmacother. 2017 96 1253-1266
32. K. Ichiyama A. Tai I. Yamamoto Augmentation of antigen-specific antibody production and IL-10 generation with a fraction from Rooibos (Aspalathus linearis) tea Biosci., Biotechnol., Biochem. 2007 71 598-602
33. S. E. Smit R. Johnson M. A. Van Vuuren B. Huisamen Myocardial Glucose Clearance by Aspalathin Treatment in Young, Mature, and Obese Insulin-Resistant Rats Planta Med. 2018 84 75-82
34. F. Santilli M. T. Guagnano N. Vazzana S. La Barba G. Davi Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach Curr. Med. Chem. 2015 22 582-595
35. X. D. Yang S. Jiang G. Wang R. Zhang J. Zhang J. S. Zhu Link of obesity and gastrointestinal cancer: crossroad of inflammation and oxidative stress J. Biol. Regul. Homeostatic Agents 2015 29 755-760
36. P. Manna S. K. Jain Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies Metab. Syndr. Relat. Disord. 2015 13 423-444
37. L. Huo D. J. Magliano F. Ranciere J. L. Harding N. Nanayakkara J. E. Shaw B. Carstensen Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997-2011 Diabetologia 2018 61 5 1055-1063
38. B. W. McCrindle C. Manlhiot Elevated atherogenic lipoproteins in childhood: Risk, prevention, and treatment J. Clin. Lipidol. 2008 2 138-146
39. J. R. Pharr C. A. Coughenour T. J. Bungum An assessment of the relationship of physical activity, obesity, and chronic diseases/conditions between active/obese and sedentary/normal weight American women in a national sample Public Health 2018 156 117-123
40. C. Cobbold Type 2 diabetes mellitus risk and exercise: is resistin involved? J. Sports Med. Phys. Fitness 2018 10.23736/S0022-4707.18.08258-0
41. S. Horsburgh P. Robson-Ansley R. Adams C. Smith Exercise and inflammation-related epigenetic modifications: focus on DNA methylation Exercise Immunol. Rev. 2015 21 26-41
42. D. De Smedt J. De Sutter M. De Pauw H. Vandekerckhove J. Trouerbach G. De Backer A. M. Willems S. Pardaens P. Vervaet N. Deweerdt D. De Bacquer Lifestyle behaviour and risk factor control in coronary patients: Belgian results from the cross-sectional EUROASPIRE surveys Acta Cardiol. 2018 1-7
43. I. Birlouez-Aragon G. Saavedra F. J. Tessier A. Galinier L. Ait-Ameur F. Lacoste C. N. Niamba N. Alt V. Somoza J. M. Lecerf A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases Am. J. Clin. Nutr. 2010 91 1220-1226
44. K. Sebekova V. Somoza Dietary advanced glycation endproducts (AGEs) and their health effects-PRO Mol. Nutr. Food Res. 2007 51 1079-1084
45. P. C. Gregorio G. Favretto G. L. Sassaki R. S. Cunha A. Becker-Finco R. Pecoits-Filho W. M. Souza F. C. Barreto A. E. M. Stinghen Sevelamer reduces endothelial inflammatory response to advanced glycation end products Clin. Kidney J. 2018 11 89-98
46. J. Uribarri W. Cai O. Sandu M. Peppa T. Goldberg H. Vlassara Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects Ann. N. Y. Acad. Sci. 2005 1043 461-466
47. W. Cai M. Ramdas L. Zhu X. Chen G. E. Striker H. Vlassara Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1 Proc. Natl. Acad. Sci. U. S. A. 2012 109 15888-15893
48. C. Luevano-Contreras M. E. Garay-Sevilla K. Wrobel J. M. Malacara Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus J. Clin. Biochem. Nutr. 2013 52 22-26
49. M. Negrean A. Stirban B. Stratmann T. Gawlowski T. Horstmann C. Gotting K. Kleesiek M. Mueller-Roesel T. Koschinsky J. Uribarri H. Vlassara D. Tschoepe Effects of low-and high-advanced glycation endproduct meals on macro-and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus Am. J. Clin. Nutr. 2007 85 1236-1243
50. S. Yamagishi T. Matsui S. Ueda K. Nakamura T. Imaizumi Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes Cardiovasc. Hematol. Agents Med. Chem. 2007 5 236-240
51. R. Bucala K. J. Tracey A. Cerami Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes J. Clin. Invest. 1991 87 432-438
52. S. Yamagishi M. Takeuchi H. Inoue Olmesartan medoxomil, a newly developed angiotensin II type 1 receptor antagonist, protects against renal damage in advanced glycation end product (age)-injected rats Drugs Exp. Clin. Res. 2005 31 45-51
53. B. Xu Y. Ji K. Yao Y. X. Cao A. Ferro Inhibition of human endothelial cell nitric oxide synthesis by advanced glycation end-products but not glucose: relevance to diabetes Clin. Sci. 2005 109 439-446
54. U. Chakravarthy R. G. Hayes A. W. Stitt E. McAuley D. B. Archer Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products Diabetes 1998 47 945-952
55. E. S. Ganotakis J. A. Papadakis G. E. Vrentzos D. P. Mikhailidis The effects of antihypertensive therapy on haemostatic parameters Curr. Pharm. Des. 2003 9 2445-2464
56. A. Nenna C. Spadaccio M. Lusini L. Ulianich M. Chello F. Nappi Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications Recent Adv. Cardiovasc. Drug Discovery 2015 10 10-33
57. I. A. Persson The pharmacological mechanism of angiotensin-converting enzyme inhibition by green tea, Rooibos and enalaprilat-a study on enzyme kinetics Phytother. Res. 2012 26 517-521
58. E. Joubert W. C. Gelderblom A. Louw D. de Beer South African herbal teas: Aspalathus linearis, Cyclopia spp. and Athrixia phylicoides-a review J. Ethnopharmacol. 2008 119 376-412
59. N. Krafczyk F. Woyand M. A. Glomb Structure-antioxidant relationship of flavonoids from fermented rooibos Mol. Nutr. Food Res. 2009 53 635-642
60. M. J. Son M. Minakawa Y. Miura K. Yagasaki Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice Eur. J. Nutr. 2013 52 1607-1619
61. A. Kawano H. Nakamura S. Hata M. Minakawa Y. Miura K. Yagasaki Hypoglycemic effect of aspalathin, a rooibos tea component from Aspalathus linearis, in type 2 diabetic model db/db mice Phytomedicine 2009 16 437-443
62. C. J. Muller E. Joubert C. Pheiffer S. Ghoor M. Sanderson N. Chellan S. J. Fey J. Louw Z-2-(beta-D-glucopyranosyloxy)-3-phenylpropenoic acid, an alpha-hydroxy acid from rooibos (Aspalathus linearis) with hypoglycemic activity Mol. Nutr. Food Res. 2013 57 2216-2222
63. J. M. Stephens P. H. Pekala Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3 T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis J. Biol. Chem. 1992 267 13580-13584
64. G. S. Hotamisligil P. Arner J. F. Caro R. L. Atkinson B. M. Spiegelman Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance J. Clin. Invest. 1995 95 2409-2415
65. G. S. Hotamisligil N. S. Shargill B. M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 1993 259 87-91
66. K. Prasad S. Tiwari Therapeutic Interventions for Advanced Glycation-End Products and its Receptor-Mediated Cardiovascular Disease Curr. Pharm. Des. 2017 23 937-943
67. A. Prasad P. Bekker S. Tsimikas Advanced glycation end products and diabetic cardiovascular disease Cardiol. Rev. 2012 20 177-183
68. Z. Hegab S. Gibbons L. Neyses M. A. Mamas Role of advanced glycation end products in cardiovascular disease World J. Cardiol. 2012 4 90-102
69. P. V. Dludla C. J. Muller J. Louw E. Joubert R. Salie A. R. Opoku R. Johnson The cardioprotective effect of an aqueous extract of fermented rooibos (Aspalathus linearis) on cultured cardiomyocytes derived from diabetic rats Phytomedicine 2014 21 595-601
70. A. J. Grippo A. K. Johnson Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models Stress 2009 12 1-21
71. A. Chaddha E. A. Robinson E. Kline-Rogers T. Alexandris-Souphis M. Rubenfire Mental Health and Cardiovascular Disease Am. J. Med. 2016 129 1145-1148
72. E. B. Geer J. Islam C. Buettner Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism Endocrinol. Metab. Clin. North Am. 2014 43 75-102
73. L. Mathews O. Ogunmoroti K. Nasir R. S. Blumenthal O. A. Utuama M. Rouseff S. Das E. Veledar T. Feldman A. Agatston D. Zhao E. D. Michos Psychological Factors and Their Association with Ideal Cardiovascular Health Among Women and Men J. Womens Health 2018 27 5 709-715
74. L. Yang K. Korhonen H. Moustgaard K. Silventoinen P. Martikainen Pre-existing depression predicts survival in cardiovascular disease and cancer J. Epidemiol. Community Health 2018 72 7 617-622
75. C. Smith M. F. Essop Influence of lifestyle choices on metabolic risk results in distinct gender-and age-differences. Int. J. Clin. Exp. Physiol. 2014 1 13-19
76. M. O. Murphy D. M. Cohn A. S. Loria Developmental origins of cardiovascular disease: Impact of early life stress in humans and rodents Neurosci. Biobehav. Rev. 2017 74 453-465
77. A. P. Harris M. C. Holmes E. R. de Kloet K. E. Chapman J. R. Seckl Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour Psychoneuroendocrinology 2013 38 648-658
78. E. R. de Kloet C. Otte R. Kumsta L. Kok M. H. Hillegers H. Hasselmann D. Kliegel M. Joels Stress and Depression: a Crucial Role of the Mineralocorticoid Receptor J. Neuroendocrinol. 2016 28 8 10.1111/jne.12379
79. N. Nikkheslat P. A. Zunszain M. A. Horowitz I. G. Barbosa J. A. Parker A. M. Myint M. J. Schwarz A. T. Tylee L. A. Carvalho C. M. Pariante Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression Brain, Behav., Immun. 2015 48 8-18
80. E. Sahafi M. Peeri M. J. Hosseini M. A. Azarbyjani Cardiac oxidative stress following maternal separation stress was mitigated following adolescent voluntary exercise in adult male rat Physiol. Behav. 2018 183 39-45
81. S. W. Sties L. V. Andreato T. de Carvalho A. I. Gonzales V. G. Angarten A. Z. Ulbrich L. S. de Mara A. S. Netto E. L. da Silva A. Andrade Influence of exercise on oxidative stress in patients with heart failure Heart Failure Rev. 2018 23 225-235
82. R. Bonafede W. Manucha Nitric oxide and related factors linked to oxidation and inflammation as possible biomarkers of heart failure Clin. Invest. Arterioscler. 2018 30 84-94
83. I. A. Persson K. Persson S. Hagg R. G. Andersson Effects of green tea, black tea and Rooibos tea on angiotensin-converting enzyme and nitric oxide in healthy volunteers Public Health Nutr. 2010 13 730-737
84. L. Schloms A. C. Swart Rooibos flavonoids inhibit the activity of key adrenal steroidogenic enzymes, modulating steroid hormone levels in H295R cells Molecules 2014 19 3681-3695
85. L. Schloms K. H. Storbeck P. Swart W. C. Gelderblom A. C. Swart The influence of Aspalathus linearis (Rooibos) and dihydrochalcones on adrenal steroidogenesis: quantification of steroid intermediates and end products in H295R cells J. Steroid Biochem. Mol. Biol. 2012 128 128-138
86. C. M. Grombein Q. Hu R. Heim S. Rau C. Zimmer R. W. Hartmann 1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols: a new class of potent and selective aldosterone synthase inhibitors Eur. J. Med. Chem. 2015 89 597-605
87. M. Voets I. Antes C. Scherer U. Muller-Vieira K. Biemel C. Barassin S. Marchais-Oberwinkler R. W. Hartmann Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosis J. Med. Chem. 2005 48 6632-6642
88. R. W. Hartmann U. Muller P. B. Ehmer Discovery of selective CYP11B2 (aldosterone synthase) inhibitors for the therapy of congestive heart failure and myocardial fibrosis Eur. J. Med. Chem. 2003 38 363-366
89. C. Newton-Cheh T. Johnson V. Gateva M. D. Tobin M. Bochud L. Coin S. S. Najjar J. H. Zhao S. C. Heath S. Eyheramendy K. Papadakis B. F. Voight L. J. Scott F. Zhang M. Farrall T. Tanaka C. Wallace J. C. Chambers K. T. Khaw P. Nilsson P. van der Harst S. Polidoro D. E. Grobbee N. C. Onland-Moret M. L. Bots L. V. Wain K. S. Elliott A. Teumer J. Luan G. Lucas J. Kuusisto P. R. Burton D. Hadley W. L. McArdle M. Brown A. Dominiczak S. J. Newhouse N. J. Samani J. Webster E. Zeggini J. S. Beckmann S. Bergmann N. Lim K. Song P. Vollenweider G. Waeber D. M. Waterworth X. Yuan L. Groop M. Orho-Melander A. Allione A. Di Gregorio S. Guarrera S. Panico F. Ricceri V. Romanazzi C. Sacerdote P. Vineis I. Barroso M. S. Sandhu R. N. Luben G. J. Crawford P. Jousilahti M. Perola M. Boehnke L. L. Bonnycastle F. S. Collins A. U. Jackson K. L. Mohlke H. M. Stringham T. T. Valle C. J. Willer R. N. Bergman M. A. Morken A. Doring C. Gieger T. Illig T. Meitinger E. Org A. Pfeufer H. E. Wichmann S. Kathiresan J. Marrugat C. J. O'Donnell S. M. Schwartz D. S. Siscovick I. Subirana N. B. Freimer A. L. Hartikainen M. I. McCarthy P. F. O'Reilly L. Peltonen A. Pouta P. E. de Jong H. Snieder W. H. van Gilst R. Clarke A. Goel A. Hamsten J. F. Peden U. Seedorf A. C. Syvanen G. Tognoni E. G. Lakatta S. Sanna P. Scheet D. Schlessinger A. Scuteri M. Dorr F. Ernst S. B. Felix G. Homuth R. Lorbeer T. Reffelmann R. Rettig U. Volker P. Galan I. G. Gut S. Hercberg G. M. Lathrop D. Zelenika P. Deloukas N. Soranzo F. M. Williams G. Zhai V. Salomaa M. Laakso R. Elosua N. G. Forouhi H. Volzke C. S. Uiterwaal Y. T. van der Schouw M. E. Numans G. Matullo G. Navis G. Berglund S. A. Bingham J. S. Kooner J. M. Connell S. Bandinelli L. Ferrucci H. Watkins T. D. Spector J. Tuomilehto D. Altshuler D. P. Strachan M. Laan P. Meneton N. J. Wareham M. Uda M. R. Jarvelin V. Mooser O. Melander R. J. Loos P. Elliott G. R. Abecasis M. Caulfield P. B. Munroe Genome-wide association study identifies eight loci associated with blood pressure Nat. Genet. 2009 41 666-676
90. E. P. Hong D. H. Kim J. G. Suh J. W. Park Genetic risk assessment for cardiovascular disease with seven genes associated with plasma C-reactive protein concentrations in Asian populations Hypertens. Res. 2014 37 692-698
91. N. M. Francisco and M.Tech, Cape Peninsula University of Technology, 2010
92. L. Schloms C. Smith K. H. Storbeck J. L. Marnewick P. Swart A. C. Swart Rooibos influences glucocorticoid levels and steroid ratios in vivo and in vitro: a natural approach in the management of stress and metabolic disorders? Mol. Nutr. Food Res. 2014 58 537-549
93. W. L. Miller R. J. Auchus The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders Endocr. Rev. 2011 32 81-151
94. S. Ohno S. Shinoda S. Toyoshima H. Nakazawa T. Makino S. Nakajin Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells J. Steroid Biochem. Mol. Biol. 2002 80 355-363
95. J. W. Tomlinson P. M. Stewart Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome Nat. Clin. Pract. Endocrinol. Metab. 2005 1 92-99
96. P. Poirier T. D. Giles G. A. Bray Y. Hong J. S. Stern F. X. Pi-Sunyer R. H. Eckel Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism Circulation 2006 113 898-918
97. G. P. Vinson The mislabelling of deoxycorticosterone: making sense of corticosteroid structure and function J. Endocrinol. 2011 211 3-16
98. S. M. MacKenzie D. Dewar W. Stewart R. Fraser J. M. Connell E. Davies The transcription of steroidogenic genes in the human cerebellum and hippocampus: a comparative survey of normal and Alzheimer's tissue J. Endocrinol. 2008 196 123-130
99. S. S. Girdler R. Klatzkin Neurosteroids in the context of stress: implications for depressive disorders Pharmacol. Ther. 2007 116 125-139
100. M. C. Holmes J. R. Seckl The role of 11beta-hydroxysteroid dehydrogenases in the brain Mol. Cell. Endocrinol. 2006 248 9-14
101. T. C. Sandeep J. L. Yau A. M. MacLullich J. Noble I. J. Deary B. R. Walker J. R. Seckl 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics Proc. Natl. Acad. Sci. U. S. A. 2004 101 6734-6739
102. C. S. Wyrwoll M. C. Holmes J. R. Seckl 11beta-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress Front Neuroendocrinol. 2011 32 265-286
103. E. R. de Kloet From receptor balance to rational glucocorticoid therapy Endocrinology 2014 155 2754-2769
104. E. Gomez-Sanchez C. E. Gomez-Sanchez The multifaceted mineralocorticoid receptor Compr. Physiol. 2014 4 965-994
105. H. van der Woude M. G. Ter Veld N. Jacobs P. T. van der Saag A. J. Murk I. M. Rietjens The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor Mol. Nutr. Food Res. 2005 49 763-771
106. S. Ruhs N. Stratz K. Schlor S. Meinel S. Mildenberger S. Rabe M. Gekle C. Grossmann Modulation of transcriptional mineralocorticoid receptor activity by nitrosative stress Free Radicals Biol. Med. 2012 53 1088-1100
107. T. Breiter C. Laue G. Kressel S. Groll U. H. Engelhardt A. Hahn Bioavailability and antioxidant potential of rooibos flavonoids in humans following the consumption of different rooibos formulations Food Chem. 2011 128 338-347
108. C. P. Yu P. P. Wu Y. C. Hou S. P. Lin S. Y. Tsai C. T. Chen P. D. Chao Quercetin and rutin reduced the bioavailability of cyclosporine from Neoral, an immunosuppressant, through activating P-glycoprotein and CYP 3A4 J. Agric. Food Chem. 2011 59 4644-4648
109. L. Quintieri P. Palatini A. Nassi P. Ruzza M. Floreani Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes Biochem. Pharmacol. 2008 75 1426-1437
110. O. Patel C. Muller E. Joubert J. Louw B. Rosenkranz C. Awortwe Inhibitory Interactions of Aspalathus linearis (Rooibos) Extracts and Compounds, Aspalathin and Z-2-(beta-d-Glucopyranosyloxy)-3-phenylpropenoic Acid, on Cytochromes Metabolizing Hypoglycemic and Hypolipidemic Drugs Molecules 2016 21 11 pii: E1515
111. A. Crozier D. Del Rio M. N. Clifford Bioavailability of dietary flavonoids and phenolic compounds Mol. Aspects Med. 2010 31 446-467
112. Y. Minamiyama S. Takemura T. Akiyama S. Imaoka M. Inoue Y. Funae S. Okada Isoforms of cytochrome P450 on organic nitrate-derived nitric oxide release in human heart vessels FEBS Lett. 1999 452 165-169
113. T. C. Delozier G. E. Kissling S. J. Coulter D. Dai J. F. Foley J. A. Bradbury E. Murphy C. Steenbergen D. C. Zeldin J. A. Goldstein Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues Drug Metab. Dispos. 2007 35 682-688
114. V. Michaud M. Frappier M. C. Dumas J. Turgeon Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism PLoS One 2010 5 e15666
115. S. S. Bolz B. Fisslthaler S. Pieperhoff C. De Wit I. Fleming R. Busse U. Pohl Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca(2+) changes and dilation in isolated resistance arteries FASEB J. 2000 14 255-260
116. A. Mancy S. Dijols S. Poli P. Guengerich D. Mansuy Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9 Biochemistry 1996 35 16205-16212
117. A. P. Simopoulos The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases Exp. Biol. Med. 2008 233 674-688
118. A. P. Simopoulos Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases Biomed. Pharmacother. 2006 60 502-507
119. E. Mourmoura G. Vial B. Laillet J. P. Rigaudiere I. Hininger-Favier H. Dubouchaud B. Morio L. Demaison Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo Cardiovasc. Diabetol. 2013 12 49
120. R. J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol. Rev. 2002 82 131-185
121. A. Aghazadeh-Habashi W. Asghar F. Jamali Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid J. Pharm. Sci. 2018 107 756-763
122. I. Fleming Vascular cytochrome p450 enzymes: physiology and pathophysiology Trends Cardiovasc. Med. 2008 18 20-25
123. A. Polonikov A. Kharchenko M. Bykanova S. Sirotina I. Ponomarenko A. Bocharova K. Vagaytseva V. Stepanov O. Bushueva M. Churnosov M. Solodilova Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population Gene 2017 627 451-459
124. Y. Yang R. Dong Z. Chen D. Hu M. Fu Y. Tang D. W. Wang X. Xu L. Tu Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance Aging Cell 2018 17 2 10.1111/acel.12718
125. N. Bunimov O. Laneuville Cyclooxygenase inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis Cardiovasc. Hematol. Disord. Drug Targets 2008 8 268-277
126. M. Mutoh M. Takahashi K. Fukuda H. Komatsu T. Enya Y. Matsushima-Hibiya H. Mutoh T. Sugimura K. Wakabayashi Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship Jpn. J. Cancer Res. 2000 91 686-691
127. H. K. Na K. S. Mossanda J. Y. Lee Y. J. Surh Inhibition of phorbol ester-induced COX-2 expression by some edible African plants Biofactors 2004 21 149-153
128. C. M. Park Y. S. Song Luteolin and luteolin-7-O-glucoside inhibit lipopolysaccharide-induced inflammatory responses through modulation of NF-kappaB/AP-1/PI3K-Akt signaling cascades in RAW 264.7 cells Nutr. Res. Pract. 2013 7 423-429
129. X. Qin Y. Lu Z. Peng S. Fan Y. Yao Systematic Chemical Analysis Approach Reveals Superior Antioxidant Capacity via the Synergistic Effect of Flavonoid Compounds in Red Vegetative Tissues Front. Chem. 2018 6 9
130. A. C. Bennett A. Van Camp V. Lopez C. Smith Sceletium tortuosum may delay chronic disease progression via alkaloid-dependent antioxidant or anti-inflammatory action J. Physiol. Biochem. 2018 10.1007/s13105-018-0620-6
131. C. J. Muller E. Joubert D. de Beer M. Sanderson C. J. Malherbe S. J. Fey J. Louw Acute assessment of an aspalathin-enriched green rooibos (Aspalathus linearis) extract with hypoglycemic potential Phytomedicine 2012 20 32-39
132. S. Nagai C. Matsumoto M. Shibano K. Fujimori Suppression of Fatty Acid and Triglyceride Synthesis by the Flavonoid Orientin through Decrease of C/EBPdelta Expression and Inhibition of PI3K/Akt-FOXO1 Signaling in Adipocytes Nutrients 2018 10 2 pii: E130
133. F. Li J. Zong H. Zhang P. Zhang L. Xu K. Liang L. Yang H. Yong W. Qian Orientin Reduces Myocardial Infarction Size via eNOS/NO Signaling and Thus Mitigates Adverse Cardiac Remodeling Front. Pharmacol. 2017 8 926
134. S. Kwak M. S. Han J. S. Bae Aspalathin and nothofagin from rooibos (Aspalathus linearis) inhibit endothelial protein C receptor shedding in vitro and in vivo Fitoterapia 2015 100 179-186
135. C. L. de Almeida Diuretic, natriuretic and potassium-sparing effect of nothofagin isolated from Leandra dasytricha (A Gray) Cogn. leaves in normotensive and hypertensive rats Chem.-Biol. Interact. 2017 103-110
136. C. L. de Almeida Prolonged diuretic and saluretic effect of nothofagin isolated from Leandra dasytricha (A Gray) Cogn. leaves in normotensive and hypertensive rats: role of antioxidant system and renal protection Chem.-Biol. Interact. 2018 227-233
137. S. Habtemariam G. Lentini The therapeutic potential of rutin for diabetes: an update Mini-Rev. Med. Chem. 2015 15 524-528
138. R. V. Patel B. M. Mistry R. Syed A. K. Rathi Y. S. Keum Quercetin: A plant-derived polyphenol with tremendous cardioprotective effects Mini-Rev. Med. Chem. 2018 10.2174/1389557518666180305162455
139. Y. Luo P. Shang D. Li Luteolin: A Flavonoid that Has Multiple Cardio-Protective Effects and Its Molecular Mechanisms Front. Pharmacol. 2017 8 692
140. X. Che X. Wang J. Zhang C. Peng Y. Zhen X. Shao G. Zhang L. Dong Vitexin exerts cardioprotective effect on chronic myocardial ischemia/reperfusion injury in rats via inhibiting myocardial apoptosis and lipid peroxidation Am. J. Transl. Res. 2016 8 3319-3328
141. L. Y. Dong S. Li Y. L. Zhen Y. N. Wang X. Shao Z. G. Luo Cardioprotection of vitexin on myocardial ischemia/reperfusion injury in rat via regulating inflammatory cytokines and MAPK pathway Am. J. Chin. Med. 2013 41 1251-1266
142. R. Ashokkumar S. Jamuna M. S. Sakeena Sadullah S. Niranjali Devaraj Vitexin protects isoproterenol induced post myocardial injury by modulating hipposignaling and ER stress responses Biochem. Biophys. Res. Commun. 2018 496 731-737
143. M. Burkitt Too much of a good thing? Nat. Biotechnol. 2001 19 811
144. C. Y. Lee A. Sharma R. L. Uzarski J. E. Cheong H. Xu R. A. Held S. K. Upadhaya J. L. Nelson Potent antioxidant dendrimers lacking pro-oxidant activity Free Radicals Biol. Med. 2011 50 918-925
145. J. K. Shin G. N. Kim H. D. Jang Antioxidant and pro-oxidant effects of green tea extracts in oxygen radical absorbance capacity assay J. Med. Food 2007 10 32-40
146. C. Villanueva R. D. Kross Antioxidant-induced stress Int. J. Mol. Sci. 2012 13 2091-2109
147. M. Sinisalo A. L. Enkovaara K. T. Kivisto Possible hepatotoxic effect of rooibos tea: a case report Eur. J. Clin. Pharmacol. 2010 66 427-428
148. C. Batista N. R. Jesus C. M. Silva T. P. Silva M. G. Campos Herb-Drug Interactions: An Insight into Cardiovascular Diseases Based on Case Reports Cardiovasc. Hematol. Agents Med. Chem. 2017 14 142-149